Showing results (41-50 of 509) with videos related to
Sort By:
Pageof 51
Clinical Lung Cancer|August 17, 2024
Association Between PD-L1 Score and the Outcomes of Consolidation Durvalumab in a Large Nationwide Series of Patients With Stage III NSCLC Treated With ChemoradiotherapyRonald Damhuis, Idris Bahce, Suresh SenanJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 1, 2013
Radiotherapy for intubated patients with malignant airway obstruction: futile or facilitating extubation?Alexander V Louie, Sophia Lane, David A Palma, et al.International Journal of Radiation Oncology, Biology, Physics|April 4, 2015
Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial? A multi-institutional propensity score matched analysisGeorge Rodrigues, Cary Oberije, Suresh Senan, et al.International Journal of Radiation Oncology, Biology, Physics|September 17, 2013
Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysisDavid A Palma, Suresh Senan, Cary Oberije, et al.International Journal of Radiation Oncology, Biology, Physics|June 17, 2020
Is There a Role for Hypofractionated Thoracic Radiation Therapy in Limited-Stage Small Cell Lung Cancer? A Propensity Score Matched AnalysisSondos Zayed, Hanbo Chen, Emma Ali, et al.European Respiratory Review : an Official Journal of the European Respiratory Society|May 6, 2021
Developments in radiation techniques for thoracic malignanciesTobias Finazzi, Famke L Schneiders, Suresh SenanRadiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 15, 2024
Sub-lobar resections for peripheral non-small cell lung cancer measuring ≤ 2 cm: Insights from recent clinical trialsSuresh Senan, Famke L Schneiders, Drew MoghanakiInternational Journal of Radiation Oncology, Biology, Physics|June 28, 2025
Treatment Toxicity and Outcomes Following Definitive Radiation Therapy for Patients With Early-Stage Non-Small Cell Lung Cancers and Pre-Existing Interstitial Lung Disease-A Systematic Review and Dosimetric AnalysisGeorge J Li, Melissa Sam Soon, Hanbo Chen, et al.International Journal of Radiation Oncology, Biology, Physics|February 13, 2016
Factors Associated With Early Mortality in Patients Treated With Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung CancerAndrew Warner, Max Dahele, Bo Hu, et al.International Journal of Radiation Oncology, Biology, Physics|January 15, 2022
Determining Planning Priorities for SABR for Oligometastatic Disease: A Secondary Analysis of the SABR-COMET Phase II Randomized TrialMatthew Van Oirschot, Alanah Bergman, Wilko F A R Verbakel, et al.Pageof 51